Long-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Pediatric ORION-16, ORION-13, ORION-20, or ORION-19 Studies

ישראלמגייס משתתפיםPHASE3

מצבים רפואיים

Heterozygous or Homozygous Familial Hypercholesterolemia

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • Novartis Investigative Site, Jerusalem, Israel

  • Novartis Investigative Site, Ramat Gan, Israel

  • Excel Medical Clinical Trials LLC, Boca Raton, Florida, United States

  • Icahn School of Med at Mt Sinai, New York, New York, United States

  • Cincinnati Childrens Hospital MC, Cincinnati, Ohio, United States

  • Childrens Hosp Pittsburgh UPMC, Pittsburgh, Pennsylvania, United States

  • Primary Childrens Medical Center, Salt Lake City, Utah, United States

  • Novartis Investigative Site, Formosa, Formosa Province, Argentina

  • Novartis Investigative Site, Fortaleza, Ceará, Brazil

  • Novartis Investigative Site, São Paulo, São Paulo, Brazil

  • Novartis Investigative Site, São Paulo, São Paulo, Brazil

  • Novartis Investigative Site, Québec, Quebec, Canada

  • Novartis Investigative Site, Prague, Czechia

  • Novartis Investigative Site, Prague, Czechia

  • Novartis Investigative Site, Besançon, France

  • Novartis Investigative Site, Toulouse, France

  • Novartis Investigative Site, Frankfurt am Main, Hesse, Germany

  • Novartis Investigative Site, Freiburg im Breisgau, Germany

  • Novartis Investigative Site, Athens, Greece

  • Novartis Investigative Site, Athens, Greece

  • Novartis Investigative Site, Pécs, Baranya, Hungary

  • Novartis Investigative Site, Milan, MI, Italy

  • Novartis Investigative Site, Modena, MO, Italy

  • Novartis Investigative Site, Roma, RM, Italy

  • Novartis Investigative Site, Roma, RM, Italy

  • Novartis Investigative Site, Irbid, Jordan

  • Novartis Investigative Site, Beirut, Lebanon

  • Novartis Investigative Site, Beirut, Lebanon

  • Novartis Investigative Site, Sungai Buloh, Selangor, Malaysia

  • Novartis Investigative Site, Kuala Lumpur, Malaysia

  • Novartis Investigative Site, Amsterdam, North Holland, Netherlands

  • Novartis Investigative Site, Rotterdam, South Holland, Netherlands

  • Novartis Investigative Site, Oslo, Norway

  • Novartis Investigative Site, Gdansk, Poland

  • Novartis Investigative Site, Lodz, Łódź Voivodeship, Poland

  • Novartis Investigative Site, Kemerovo, Russia

  • Novartis Investigative Site, Moscow, Russia

  • Novartis Investigative Site, Poprad, Slovakia

  • Novartis Investigative Site, Ljubljana, Slovenia

  • Novartis Investigative Site, Bloemfontein, Free State, South Africa

  • Novartis Investigative Site, Cape Town, Western Cape, South Africa

  • Novartis Investigative Site, Pamplona, Navarre, Spain

  • Novartis Investigative Site, Oviedo, Principality of Asturias, Spain

  • Novartis Investigative Site, A Coruña, Spain

  • Novartis Investigative Site, Córdoba, Spain

  • Novartis Investigative Site, Geneva, Switzerland

  • Novartis Investigative Site, Taipei, Taiwan

  • Novartis Investigative Site, Istanbul, Fatih, Turkey (Türkiye)

  • Novartis Investigative Site, Adana, Saricam, Turkey (Türkiye)

  • Novartis Investigative Site, Ankara, Yenimahalle, Turkey (Türkiye)

  • Novartis Investigative Site, Izmir, Turkey (Türkiye)

  • Novartis Investigative Site, Middlesex, United Kingdom

מובילי המחקר
  • Novartis Pharmaceuticals

    Study Director

    Novartis Pharmaceuticals